Clinical association between tacrolimus intra-patient variability and liver transplantation outcomes in patients with and without hepatocellular carcinoma
Abstract Tacrolimus is the mainstay of immunosuppression in liver transplantation to prevent rejection. However, the clinical use of tacrolimus is complicated by its narrow therapeutic window and significant intra-patient variability (IPV). High tacrolimus IPV is associated with overexposure and adv...
Main Authors: | Hyun Jeong Kim, Juhan Lee, Jae Geun Lee, Dong Jin Joo, Myoung Soo Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-09-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-022-20636-3 |
Similar Items
-
Clinical significance of tacrolimus intra-patient variability on kidney transplant outcomes according to pre-transplant immunological risk
by: Eun Jin Kim, et al.
Published: (2021-06-01) -
Cumulative exposure to tacrolimus during early period after liver transplantation does not affect the recurrence of hepatocellular carcinoma
by: Deok-Gie Kim, et al.
Published: (2023-11-01) -
Tacrolimus intra-patient variability in pediatric liver transplantation
by: WU Haoxiang, LÜ Zicheng, HOU Yuchen, ZHANG Zijie, QIAO Ziyun, FENG Hao, XIA Qiang
Published: (2022-05-01) -
Antiplatelet Drugs on the Recurrence of Hepatocellular Carcinoma after Liver Transplantation
by: Mun Chae Choi, et al.
Published: (2022-10-01) -
Impact of everolimus on survival after liver transplantation for hepatocellular carcinoma
by: Incheon Kang, et al.
Published: (2021-10-01)